Rheumatoid Arthritis

Menopause, obesity, and bacterial infection all have a negative impact on RA, according to 3 recent studies.

The EULAR definition of arthralgia suspicious for progression to RA was recently validated.

Drink up-but in moderation.

A reliable biomarker linked to outcomes represents another step toward the goal of individualized treatment.

An accurate, inexpensive alternative for examining smaller joints is at hand.

While vitamin D may help ward off the onset of RA, it is less effective once the disease is established.

Early intervention may prevent or delay the development of RA.

The monotherapy resulted in LDA by week 14 in both the 15 mg (45%) and 30 mg (53%) groups.

New evidence is reassuring for women with rheumatoid arthritis who need treatment with a biologic throughout pregnancy.

The incretin-insulin axis and incretin effect are disrupted in patients with RA.

Patients who have RA and interstitial lung disease are at higher risk for dying than those who do not.

Exposure to cold environments has been linked to disease development, and new findings may help prevention.

This modality may enhance the diagnostic workup of patients with early arthralgia at risk for inflammatory arthritis.

Improvement in DAS28 scores was statistically significant in 26% of patients using adalimumab every 3 weeks compared to every 2 weeks.

The higher the dose the patient is exposed to, the greater the risk.

The live varicella-zoster vaccine may be effective in patients with RA who are starting treatment with tofacitinib.

The study showed positive results in a difficult-to-treat patient population.

A different course, symptoms, and perceptions often results in different coping strategies and maybe even destructive behaviors.

Joint swelling has the best concordance with ultrasound diagnosis. Joint symptoms may be a better clinical indicator than tenderness evaluation.

Tumor necrosis factor inhibitors and high-dose corticosteroids were the culprits.

In a letter to the company, the FDA cited safety and dosage concerns as major factors in their decision.

Used with or separate from traditional measures, this tool can obtain a fast assessment of remission.

The new janus kinase 1 inhibitor used in combination with MTX produced rapid improvement in symptoms.

Tocilizumab may be associated with increasing LDL cholesterol in rheumatoid arthritis, but a new study shows that it is not associated with increased cardiovascular risk.

The drug helped patients achieve clinical remission, low disease activity.